HS OBTAIN
HS OBTAIN study with Sanofi
0 ratings
Archived App (Last seen on 8 Sep 2026)
This is an archived listing of the app previously available on the App Store.Although the app is no longer distributed by Apple, you can still view its description, screenshots, version history, ratings, and metadata for reference.
About
This is the HS OBTAIN study with Sanofi assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY molecule, SAR442970 in participants with moderate to severe hidradenitis suppurativa.
What's New in HS OBTAIN
1.2.71
September 30, 2024
iOS 18 compatibility
